EUVIMED · CrossrefZeitschrift
Toxicology and Applied Pharmacology
ISSN 0041-008X · Elsevier BV
Neueste Artikel
Liposomal Kasugamycin attenuates methylmercury chloride-induced neurotoxicity through modulation of CHI3L1-associated neuroinflammation
Oral nicotine pouch extracts disrupt osteogenic differentiation in human embryonic stem cells
Evaluating the effects of xylazine on fentanyl-induced respiratory depression and recovery with rescue agents in rats
Reversal of acquired osimertinib resistance by YAP inhibition in lung cancer is associated with lipid metabolic reprogramming
m6A-modified hsa_circ_0010996 regulates ferroptosis in anti-tuberculosis drug-induced liver injury cells by binding to EIF4A3
Placental and lactational transfer of lead across the perinatal continuum: a proof-of-concept extended PBPK model calibrated with longitudinal data from two independent human birth cohorts
Snake venom toxin-inspired peptide AMPAB5 combats multidrug-resistant bacteria and suppresses inflammatory responses in human cells
Unveiling the mechanisms of nephrotoxicity caused by the interplay of losartan and febuxostat
Oleanolic acid induces STING-dependent ferroptosis in hepatocellular carcinoma by promoting mitochondrial DNA leakage and targeting STING
Kaempferol protects against the nephrotoxic changes induced by ifosfamide: Cross-talk between apoptosis, mitochondrial dysfunction, TXNIP-associated pyroptosis, and endoplasmic reticulum stress pathways
Brexpiprazole, a third-generation atypical antipsychotic inhibits voltage-gated K+ channels in rabbit coronary artery smooth muscle cells
Retraction notice to “Paroxetine attenuates doxorubicin-induced cardiotoxicity: Integrated network pharmacology, molecular modeling, and in vivo evidence consistent with modulation of GRK2/iNOS-related pathways” [Toxicol. Appl. Pharmacol. 513 (2026) 117864]
Redox-driven disruption of nitric oxide–dependent angiogenic and inflammatory signaling in cadmium-exposed rat placenta: modulation by dietary soy
Environmental blood cadmium tracks with albuminuria at concentrations far below ToxCast AC50s
MRP4 deficiency exacerbates diet-induced MASLD through dysregulation of hepatic lipid handling
Translation from mice to monkeys toward human: species differences in endothelial-dependent vasorelaxation in various isolated vascular beds
Impact of chronic oral aflatoxin B1 exposure on iron metabolism in a pig model
Levonorgestrel-ethinyl estradiol impairs hepatic lipid clearance to induce hypercholesterolemia via PCSK9-mediated LDLR and CD36 dysregulation
Corrigendum to “Methcathinone disrupts glycerophospholipid metabolism and selectively activates the p38/COX-2 axis to induce anxiety-like behaviour in zebrafish” [Toxicol. Appl. Pharmacol. 515 (2026) 117965]
Inhibition of miR-1187 attenuates isoflurane-induced cognitive dysfunction in mice via targeting Syp
Myocardial senescence as a mechanistic endpoint of arsenic cardiotoxicity: Cysteine-associated p53/p21 activation and reversal by quercetin
Retraction notice to “Apple polyphenol phloretin complexed with ruthenium is capable of reprogramming the breast cancer microenvironment through modulation of PI3K/Akt/mTOR/VEGF pathways” [Toxicol. Appl. Pharmacol. 434 (2022) 115822]
A longitudinal characterization of cardiopulmonary and systemic injury following acute chlorine inhalation in rats
Shikonin suppresses fibrotic phenotype and oxidative stress in keloid fibroblasts via EGFR-targeted AKT/STAT3/PTGS2 modulation
Tuberostemonine produces antidepressant effects via the BDNF/TrkB/Erk/CREB signaling pathway
Mechanistic study of cycloastragenol in improving heart failure by regulating PI3K/AKT/mTOR signaling and ferroptosis
Preoperative serum miR-431-5p as a predictive biomarker for perioperative respiratory adverse events in children undergoing general anesthesia
Tubuloside A alleviates sepsis-associated kidney injury by modulating the mTOR-NF-κB pathway
NRF2 activation mediates the protective effects of capsaicin against MGO/STZ-induced chondrocyte apoptosis and diabetic articular cartilage injury
METTL3-mediated m6A modification of PARP2 accelerates hepatocellular carcinoma progression
Jahrgänge
2027 · 112026 · 2822025 · 3682024 · 2902023 · 2602022 · 3312021 · 2892020 · 3332019 · 3402018 · 3702017 · 3332016 · 3372015 · 3252014 · 3632013 · 4432012 · 3932011 · 3482010 · 3552009 · 3912008 · 4432007 · 3512006 · 3292005 · 4192004 · 3232003 · 2872002 · 2462001 · 2372000 · 2601999 · 2621998 · 2661997 · 3001996 · 3851995 · 2411994 · 2581993 · 2521992 · 2681991 · 2971990 · 2901989 · 3061988 · 293
EUVIMED